Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant

Parenterally administered rotavirus vaccines may overcome the low efficacy observed in resource-poor regions that use live oral formulations. We have reported work on a trivalent nonreplicating rotavirus vaccine (NRRV) for parenteral administration consisting of the recombinant tetanus toxoid P2 CD4...

Descripción completa

Detalles Bibliográficos
Autores principales: McAdams, David, Lakatos, Kyle, Estrada, Marcus, Chen, Dexiang, Plikaytis, Brian, Sitrin, Robert, White, Jessica A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208242/
https://www.ncbi.nlm.nih.gov/pubmed/33857473
http://dx.doi.org/10.1016/j.jim.2021.113056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208242/
https://www.ncbi.nlm.nih.gov/pubmed/33857473
http://dx.doi.org/10.1016/j.jim.2021.113056

Ejemplares similares